Opiant Pharmaceuticals Announces First Patient Dosed in
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking risk levels1 Trial is informed by...
Source: globenewswire.com
📰 Sequential Parallel Comparison Study Design News
Sequential Parallel Comparison Study Design News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sequential Parallel Comparison Study Design. Real-time updates on events, politics, business and more.